Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MM4MN-B12: Vitamin B12 Pharmacokinetics in Pregnancy
NCT05426395Phase 1Active, not recruiting
- Sponsor
- George Washington University
- Start
- Jun 2023
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of vitamin b12 in vitamin B12 deficiency (3 arms), sponsored by George Washington University. Primary endpoint: Steady state pharmacokinetics of B12 at 4 weeks. Started Jun 2023; status: active, not recruiting.
02
Drugs
vitamin b12
03
Conditions
vitamin B12 deficiency
Beyond the preview
Go deeper on NCT05426395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05426395.